Pharmacokinetics and safety of olaparib tablets as monotherapy and in combination with paclitaxel: results of a Phase I study in Chinese patients with advanced solid tumours

被引：0
|
作者：
Peng Yuan
Jianzhong Shentu
Jianming Xu
Wendy Burke
Kate Hsu
Maria Learoyd
Min Zhu
Binghe Xu
机构：
[1] Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC),National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center
[2] The First Affiliated Hospital of Zhejiang University,Research Center for Clinical Pharmacy, State Key Laboratory for Diagnosis and Treatment of Infectious Disease
[3] Academy of Military Medical Sciences,Affiliated Hospital Cancer Center, The 307th Hospital of Chinese People’s Liberation Army
[4] Covance Clinical Research Unit,undefined
[5] AstraZeneca,undefined
[6] AstraZeneca,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Chinese patients; Olaparib; Paclitaxel; PARP inhibitor; Pharmacokinetics; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：963 / 974
页数：11
相关论文
共 50 条
  • [31] Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours
    L P Martin
    M F Kozloff
    R S Herbst
    T A Samuel
    S Kim
    B Rosbrook
    M Tortorici
    Y Chen
    J Tarazi
    A J Olszanski
    T Rado
    A Starr
    R B Cohen
    British Journal of Cancer, 2012, 107 : 1268 - 1276
  • [32] Phase I study of safety, tolerability, and pharmacokinetics of pazopanib in combination with oral topotecan in patients with advanced solid tumors
    Kerklaan, Bojana Milojkovic
    Lolkema, Martijn P. J. K.
    Devriese, Lot A.
    Voest, Emile E.
    Nol-Boekel, A.
    Mergui-Roelvink, M.
    Mykulowycz, Kristine
    Stoebenau, Joseph E.
    Fang, Lei
    Legenne, Philippe
    Wissel, Paul Stephen
    Smith, Deborah A.
    Giantonio, Bruce J.
    Schellens, Jan H. M.
    Witteveen, Petronella
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours
    Khan, O. A.
    Gore, M.
    Lorigan, P.
    Stone, J.
    Greystoke, A.
    Burke, W.
    Carmichael, J.
    Watson, A. J.
    McGown, G.
    Thorncroft, M.
    Margison, G. P.
    Califano, R.
    Larkin, J.
    Wellman, S.
    Middleton, M. R.
    BRITISH JOURNAL OF CANCER, 2011, 104 (05) : 750 - 755
  • [34] Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors
    Tan, Antoinette R.
    Dowlati, Afshin
    Jones, Suzanne F.
    Infante, Jeffrey R.
    Nishioka, Jennifer
    Fang, Lei
    Hodge, Jeffrey P.
    Gainer, Shelby D.
    Arumugham, Thangam
    Suttle, A. Benjamin
    Dar, Mohammed M.
    Lager, Joanne J.
    Burris, Howard A., III
    ONCOLOGIST, 2010, 15 (12): : 1253 - 1261
  • [35] A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours
    Suder, A.
    Ang, J. E.
    Kyle, F.
    Harris, D.
    Rudman, S.
    Kristeleit, R.
    Solca, F.
    Uttenreuther-Fischer, M.
    Pemberton, K.
    Pelling, K.
    Schnell, D.
    de Bono, J.
    Spicer, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (16) : 2275 - 2284
  • [36] A phase I trial assessing the safety and pharmacokinetics of afatinib and weekly vinorelbine in patients with advanced solid tumours
    Hollebecque, A.
    Bahleda, R.
    Berge, Y.
    Massard, C.
    Uttenreuther-Fischer, M.
    De Mont-Serrat, H.
    Tschoepe, I.
    Schnell, D.
    Soria, J. C.
    Delord, J. P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S189 - S189
  • [37] A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
    Pronk, LC
    Vasey, P
    Sparreboom, A
    Reigner, B
    Planting, AST
    Gordon, RJ
    Osterwalder, B
    Verweij, J
    Twelves, C
    BRITISH JOURNAL OF CANCER, 2000, 83 (01) : 22 - 29
  • [38] A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
    Pronk L.C.
    Vasey P.
    Sparreboom A.
    Reigner B.
    Planting A.S.Th.
    Gordon R.J.
    Osterwalder B.
    Verweij J.
    Twelves C.
    British Journal of Cancer, 2000, 83 (1) : 22 - 29
  • [39] Pharmacokinetics, safety, and antitumor activity of talazoparib monotherapy in Chinese patients with advanced solid tumors
    Yang Luo
    Ying Cheng
    Chunjiao Wu
    Hui Ye
    Naihan Chen
    Fan Zhang
    Hua Wei
    Binghe Xu
    Investigational New Drugs, 2023, 41 : 503 - 511
  • [40] Pharmacokinetics, safety, and antitumor activity of talazoparib monotherapy in Chinese patients with advanced solid tumors
    Luo, Yang
    Cheng, Ying
    Wu, Chunjiao
    Ye, Hui
    Chen, Naihan
    Zhang, Fan
    Wei, Hua
    Xu, Binghe
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (03) : 503 - 511
12345